Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Omeros Corp (NASDAQ:OMER)

14.10
Delayed Data
As of Mar 28
 +1.43 / +11.29%
Today’s Change
7.20
Today|||52-Week Range
16.40
+42.14%
Year-to-Date
Omeros Rallies After OMS721 Presentation
Mar 28 / Benzinga - Paid Partner Content
 

Today’s Trading

Previous close12.67
Today’s open12.51
Day’s range12.51 - 16.40
Volume3,366,890
Average volume (3 months)511,378
Market cap$555.2M
Dividend yield--
Data as of 3:59pm ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)+17.50%
Earnings growth (this year)+25.05%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+208.07%
P/E ratioNM
Price/Sales9.64
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RETAReata Pharmaceutical...-2.43-9.54%
SPPISpectrum Pharmaceuti...-0.12-1.79%
ACHNAchillion Pharmaceut...-0.10-2.57%
CYTKCytokinetics Inc-0.20-1.57%
Data as of 3:59pm ET, 03/28/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$41.6M
Annual profit (last year)-$66.7M
Net profit margin-160.38%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
CFO, Treasurer, Chief Accounting Officer &
VP
Michael A. Jacobsen
Corporate headquarters
Seattle, Washington

Forecasts


Search for Jobs